Zhejiang University

This early-phase study tested whether combining two drugs (donafinib and an anti-PD-1 antibody) can safely prevent liver cancer from returning after surgery in patients at high risk of recurrence. 30 adults with hepatocellular carcinoma who had their tumor removed 4-8 weeks earli…

This early-phase study tested a new immune cell therapy called ThisCART19A in 10 adults with a hard-to-treat type of leukemia (B-ALL) that had come back or stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see how well the th…

This study tested whether adding an immunotherapy drug (Anti-PD-1) to standard chemotherapy could help people with locally advanced or borderline resectable pancreatic cancer. The trial involved 392 participants and compared the combination treatment to chemotherapy alone. The go…

This study tested whether a low dose of the drug chidamide, given after a donor stem cell transplant, can help prevent T-cell acute lymphoblastic leukemia or T-cell lymphoma from coming back. Forty-four patients aged 14 to 70 who were at high risk of relapse took part. The main g…

This study tested a new device called the COMBO Endoscopy Oropharyngeal Airway in 104 adults having a lung exam (bronchoscopy) under sedation. The device combines oxygen support, breathing monitoring, and a bite block to prevent low oxygen levels. Results showed it helped reduce …

This study looked at whether a high-flow nasal cannula (a device that delivers warm, moist oxygen through the nose) can prevent low oxygen levels during sedated gastrointestinal endoscopy in people at high risk for obstructive sleep apnea. The trial included 80 adults with a STOP…

This study tested whether using 3D reconstructed images of the pelvis can help doctors perform more precise prostate biopsies. A total of 436 men with suspicious prostate lesions took part. Researchers compared standard biopsy methods with a 3D imaging-assisted approach to see if…